In line with this finding, the prevalence of patients with stroke was higher among those with severe hypoglycaemic events (6.8%) compared with insulin-treated type 2 diabetes patients without severe events (3.3%) in the previous study from the US [5]. The gene discussed is INS; the disease is stroke disorder.